In this regard, TLR1, 2, and 6 expression was recently reported to be higher in CD34+ blasts from patients with lower-risk MDS than in higher-risk MDS or controls [559] whereas TLR2 and 4 expression did not differ between AML patients and healthy volunteers [560]. This evidence concerns the gene CD34 and myelodysplastic syndrome.